FDA label revised 08/2026 · prices checked Oct 2026
What Is Zepbound? Lilly's Weekly Tirzepatide Shot, KwikPen and Vials Explained
Zepbound is Eli Lilly's once-weekly tirzepatide injection, FDA-approved for chronic weight management in adults since Nov 8, 2023 and for moderate to severe sleep apnea with obesity since Dec 20, 2024.
- Tirzepatide, once a week
- FDA-approved: weight and OSA
- KwikPen, vial or single-dose pen
- Prescription only
We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure
Chia Health
Our #1 pick for GLP-1 weight loss online
- One monthly price: clinician, medication and free shipping included
- Semaglutide or tirzepatide, as a weekly injection or a daily tablet
- No insurance needed; HSA/FSA and Klarna accepted
Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure
$212.89 first month, then $349/mo
6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.
01 The basics
What Is Zepbound? The Short Version
Zepbound is the brand name Eli Lilly uses for tirzepatide when it is prescribed for weight. It is a once-weekly injection under the skin, used together with a reduced-calorie diet and more physical activity (label section 1). It needs a prescription, and every dose is measured in milligrams from a labeled pen or vial.
The label carries a boxed warning: tirzepatide caused thyroid C-cell tumors in rats, and Zepbound is not for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2 (section 4). Whether it causes these tumors in people is unknown.
02 The molecule
Zepbound Tirzepatide: How It Works and How It Differs From Mounjaro
Tirzepatide acts on two gut-hormone receptors at once, GIP and GLP-1 (label section 12.1). GLP-1 helps regulate appetite and how much you eat, and the label says the GIP part may add to that effect; both receptors sit in brain areas that control appetite. A fatty-acid chain lets the drug bind to albumin in the blood, which is why one shot lasts a week.
| Feature | Zepbound | Mounjaro |
|---|---|---|
| Active drug | tirzepatide | tirzepatide |
| Maker | Eli Lilly | Eli Lilly |
| FDA-approved for | Chronic weight management; OSA with obesity | Type 2 diabetes |
| Doses | 2.5 to 15 mg weekly | 2.5 to 15 mg weekly |
| Forms on the label | KwikPen, multi-dose vial, single-dose vial, single-dose pen | Same four forms |
| Medicare GLP-1 Bridge | $50 a month (KwikPen only) | Regular Part D, for diabetes |
Same molecule, different label, and the label says not to combine Zepbound with any other tirzepatide product or any GLP-1 drug (section 1). Is it a GLP-1? Partly: it is a dual GIP and GLP-1 agonist, explained in is Zepbound a GLP-1. Full side-by-side: Mounjaro and Zepbound guide. The molecule itself: tirzepatide.
03 Approved uses
What Zepbound Is FDA-Approved For (and What It Is Not)
Weight reduction and long-term maintenance
For adults with obesity, or adults with overweight plus at least one weight-related condition such as high blood pressure or high cholesterol (section 1). The main weight trial, SURMOUNT-1, enrolled adults with a BMI of 30 or higher, or 27 to 30 with a related condition. Maintenance doses: 5, 10 or 15 mg. Trial numbers by dose and week: Zepbound results.
Moderate to severe obstructive sleep apnea (OSA) in adults with obesity
Added Dec 20, 2024; the FDA called it the first medication approved for OSA. Approved on two 52-week trials, one in people not using a CPAP machine and one in people who were (section 14.2). Maintenance doses: 10 or 15 mg. Who qualifies and what the trials measured: Zepbound for sleep apnea.
Not FDA-approved uses
- Children and teens (safety not established, section 8.4)
- Type 2 diabetes alone: that is Mounjaro
- Psoriasis: studied with Taltz, not approved
- Together with another GLP-1 or tirzepatide drug
The psoriasis data come from Lilly's TOGETHER-PsO trial; summary in our Oct 9 news note. PCOS is not on the label either (GLP-1 for PCOS); for teens, see which GLP-1s are approved under 18. Every GLP-1 use by drug: GLP-1 uses.
04 Devices
Zepbound KwikPen vs Vials vs Single-Dose Pen
The milligram dose is the same whichever form you get. What changes is the device, how many doses it holds and what else you need. Your prescriber chooses the form, and the label requires training on that exact device before the first shot (section 2.4).
Zepbound KwikPen
Newest form, Feb 23, 2026
- Holds 4 weekly doses of one strength, 2.4 mL in total, 0.6 mL per dose (section 3)
- You attach a new pen needle every week and prime before each dose
- Throw it away after 4 doses or 30 days after first use, even if liquid is left (16.2)
- Single-patient use: never share, even with a new needle (5.10)
- Not recommended for self-injection by people who are visually impaired (2.4)
- LillyDirect self-pay: $299 / $399 / $449 by dose; Medicare GLP-1 Bridge: $50 a month
Zepbound vials
Single-dose or multi-dose
- Single-dose vial: 1 dose of 0.5 mL, sold as 1 or 4 vials per carton (16.1)
- Multi-dose vial: 4 doses of 0.6 mL, 2.4 mL in total
- New 1 mL syringe and needle for every shot (2.4)
- Multi-dose vial: throw away after 4 doses or 30 days after first use
- LillyDirect self-pay: same price as the KwikPen (4 single-dose vials = 1 month)
- Not covered by the Medicare GLP-1 Bridge
Zepbound single-dose pen
Autoinjector
- 1 dose of 0.5 mL with a hidden, built-in needle; a carton holds 4 pens (16.1)
- Nothing to attach, no priming; you press a button and it injects
- Can stay out of the fridge up to 86°F for 21 days in total (16.2)
- Outside the LillyDirect $299 self-pay offer; $499 a month under Lilly's no-coverage savings card
- Common route when insurance covers Zepbound
Vials and the KwikPen have cost the same on LillyDirect since Feb 23, 2026. Price detail by dose and the 45-day refill rule: Zepbound cost.
05 Strengths
Zepbound Pen Strengths: How Each Form Is Supplied
| Weekly dose | Single-dose pen or vial | KwikPen or multi-dose vial (4 doses) |
|---|---|---|
| 2.5 mg | 2.5 mg / 0.5 mL | 10 mg / 2.4 mL (4.17 mg/mL) |
| 5 mg | 5 mg / 0.5 mL | 20 mg / 2.4 mL (8.33 mg/mL) |
| 7.5 mg | 7.5 mg / 0.5 mL | 30 mg / 2.4 mL (12.5 mg/mL) |
| 10 mg | 10 mg / 0.5 mL | 40 mg / 2.4 mL (16.7 mg/mL) |
| 12.5 mg | 12.5 mg / 0.5 mL | 50 mg / 2.4 mL (20.8 mg/mL) |
| 15 mg | 15 mg / 0.5 mL | 60 mg / 2.4 mL (25 mg/mL) |
The "60 mg" printed on a 15 mg KwikPen is the total in the pen, not one dose: it delivers four 15 mg shots. Every Zepbound product is a clear, colorless to slightly yellow liquid; do not use it if you see particles or a color change (section 2.4). Unopened pens and vials go in the fridge at 36°F to 46°F and must never be frozen (16.2).
06 KwikPen
Using a Zepbound KwikPen: 5 Things That Differ From a Single-Dose Pen
- 01
Attach a new pen needle each week. The KwikPen has no built-in needle; keep the outer needle shield to remove the needle afterward.
- 02
Prime before every dose. Turn the knob to the prime position, point the needle up and push until it stops, then set your dose.
- 03
Hold for a slow count of 5 after the knob is pushed all the way in.
- 04
Remove the needle right away into a sharps container. Do not store the pen with a needle on.
- 05
Track the count. After the 4th dose, or 30 days after first use, the pen goes in the trash even if liquid remains.
These are highlights of Lilly's Instructions for Use, not a replacement. Full injection steps for all three devices, plus injection sites and missed doses: Zepbound doses and how to inject.
07 Doses
Zepbound Doses at a Glance
- 2.5 mg weeks 1 to 4, start only
- 5 mg maintenance
- 7.5 mg step
- 10 mg maintenance
- 12.5 mg step
- 15 mg maximum
Everyone starts at 2.5 mg once a week for 4 weeks, then moves to 5 mg (section 2.1). Your prescriber can raise the dose by 2.5 mg after at least 4 weeks on the current one, up to 15 mg. For weight, 5, 10 and 15 mg are maintenance doses; for sleep apnea, 10 or 15 mg. Full schedule, chart and missed-dose rules: Zepbound doses.
08 In numbers
Results, Side Effects and Cost in Three Numbers
Results shown are averages from a 72-week trial with diet and activity; individual results vary. Other label warnings include pancreatitis, gallbladder disease, kidney injury from dehydration and severe stomach reactions, and anyone having surgery under anesthesia should tell the care team they take it.
PlushCare works with 65+ insurers and sends FDA-approved prescriptions to your own pharmacy: $19.99 a month membership, $129 a visit without insurance.
Ask a PlushCare doctor if Zepbound fits you09 Pill vs shot
Is There a Zepbound Pill?
Pill vs shot
Can I take Zepbound as a pill?
No. As of Oct 2026, Zepbound and every other tirzepatide product are injections only. Lilly's once-daily weight-loss pill is a different drug, Foundayo (orforglipron), approved Apr 1, 2026, with LillyDirect self-pay from $149 a month. Lilly's oral option: Foundayo. Why "tirzepatide pills" sold online are not Zepbound: Zepbound pill explained.
Compounded tirzepatide sold online is not FDA-approved and is not Zepbound. More: compounded tirzepatide explained; for semaglutide, compounded semaglutide.
10 Getting it
How to Get Zepbound
Zepbound needs a prescription from a licensed clinician, in person or by telehealth. The route depends mostly on your coverage.
No insurance coverage: self-pay
LillyDirect sells the KwikPen or vials at $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg) a month with an on-time refill. Telehealth programs like Ro send the prescription and add a membership fee ($39 first month, then $74 to $149 a month at Ro). Brand-only telehealth options: Zepbound online.
Commercial insurance
If your plan covers Zepbound, Lilly's 2026 savings card can bring a fill to $25 (max $1,300 a year, expires Dec 31, 2026). Many plans require prior authorization. Plan rules and appeals: Zepbound insurance.
Medicare Part D
The Medicare GLP-1 Bridge charges $50 a month for the Zepbound KwikPen, not vials, from Jul 1, 2026 to Dec 31, 2027 if you meet the BMI rules. Amazon Pharmacy delivers the KwikPen at that copay. Rules: Medicare GLP-1 Bridge.
How Zepbound compares with semaglutide: Zepbound vs Wegovy. Safety questions about the whole class: is semaglutide safe.
11 FAQ
Zepbound FAQ
What is Zepbound used for?
Is Zepbound the same as tirzepatide?
What is the Zepbound KwikPen?
Is the Zepbound pen the same as the KwikPen?
How long does a Zepbound KwikPen last?
Is Zepbound a GLP-1?
Does Medicare cover Zepbound?
Label facts from the Zepbound Prescribing Information revised 08/2026; prices checked Oct 2026. General information, not medical advice; your prescriber decides whether Zepbound is right for you.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.
References
- Zepbound (tirzepatide) injection, Prescribing Information, revised 08/2026 (sections 1, 2.1 to 2.4, 3, 4, 5.10, 6.1, 8.4, 12.1, 14.1, 14.2, 16.1, 16.2), checked 2026-10-17, Eli Lilly / FDA, 2026
- Zepbound Instructions for Use (single-dose pen, vial, KwikPen), checked 2026-10-17, Eli Lilly, 2026
- FDA approves new medication for chronic weight management, Nov 8, 2023, U.S. Food and Drug Administration, 2023
- FDA approves first medication for obstructive sleep apnea, Dec 20, 2024, U.S. Food and Drug Administration, 2024
- Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen, Feb 23, 2026, Eli Lilly press release, 2026
- Zepbound coverage and savings (LillyDirect self-pay, 45-day refill pricing, 2026 savings card), checked 2026-10-17, Eli Lilly, 2026
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine, 2022
- Medicare GLP-1 Bridge: information for Part D plans, checked 2026-10-16, Centers for Medicare & Medicaid Services, 2026